Product Description
| Cat Number | PAD-HE104 |
|---|---|
| Category | Recombinant Protein |
| Pack Size | 100UG |
| Description | Recombinant Human PADI4 Protein is expressed from E.coli with His tag at the N-Terminus.It contains Met1-Pro663. |
| Target | PADI4 |
| Host | Human |
| Purity | > 95% as determined by Bis-Tris PAGE |
| Scientific Background | Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes. |
| Molecular Mass | The protein has a predicted MW of 76.6 kDa same as Bis-Tris PAGE result. |
| Sl Sequence | Met1-Pro663 |
| Appearance | Liquid |
| Endotoxin Levels | Less than 1 EU per μg by the LAL method. |
| Expression System | E.coli |
| Gene Id | Q9UM07 |
| Amino Acid Sequence | Recombinant Human PADI4 Protein is expressed from E.coli with His tag at the N-Terminus.It contains Met1-Pro663. |
| Storage | Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| View Document | |
| Note | The product is for research use only |
Share Item: